Harborview Medical Center in Seattle, US, has entered into a trial agreement to adopt Daxor’s BVA-100 blood volume analyser.
The hospital will use the device for the semi-automated measurement of total blood volume, red blood cell volume and plasma volume.
The Harborview Medical Center owned by King County, governed by a board of trustees and operated by the University of Washington.
It offers services such as trauma and burn care, neurosurgery, eye care, vascular, rehabilitation, sleep medicine and spine care.
Daxor is a medical instrumentation and biotechnology company.